2UF-33414-42325 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Registered in v-safe
2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-18
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains

Adult check-in
2021-01-10
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches · Be unable to do your normal daily activities

Free text: Swollen lymph node by armpit area

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Swelling · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-10	priority 2/3

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-10

Systemic reaction (other): Swollen lymph node by armpit area

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release